The next EAN Autumn School will take in place in Vienna, Austria, on 29 October – 2 November 2025.

Reports from three EAN Research Fellowship participants on their experiences in Lyon, Berlin, and London.

The Brain Innovation Days is thrilled to announce the subthemes into which the 2025 edition will be delving on 15-16 October in Brussels!

The Resident & Research Fellow Section (RRFS) Representatives Network Meeting took place in Warsaw, Poland, on 14–16 February, bringing together young neurologists and researchers from across Europe to discuss initiatives within the EAN.

The first EAN Regional Teaching Course in Portugal took place in Porto on 13-15 March. Read a full report of this very well attended teaching course.

This month, the eanCampus is highlighting the topic of neurogenetics, with several pieces of content freely accessible for non-members to enjoy.

Our summary of neurological news items the European Medicines Agency (EMA) monthly Human Medicines Newsletter.

Watch a full recording of the latest European Brain Health Summit, held in Brussels on 19 March under the heading 'Brain Health for a Resilient Europe'.

We are delighted to invite you to a Regional Teaching Session in Ayia Napa, Cyprus on 16 May 2025, where leading experts will present key topics in motor neuron disease and neurogenetics.

EAN Website Editor, Letizia Leocani, talks to Raphael Wurm, lead author of the eanNews Paper of the Month for January 2025, 'Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease'

EAN Leadership Programme participant Ana Barbara Willekens reflects on her reasons for applying and what she has learned from the two-year course.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2025.

EAN Education Committee Chair, Nathalie Nasr, provides an update on the full range of EAN learning opportunities.

Welcome to the March 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Our paper of the month for March is a phase 3 multicentre, double-blind, randomised trial investigating whether treatment with exenatide can slow the progression of Parkinson’s disease.